If you are considering a weight-loss treatment, there is usually one question waiting at the front of the queue:
How much weight will I actually lose? It is an understandable question. It is also one without a guaranteed personal answer.
Clinical studies can tell us what happened on average across a large group of people. They cannot look into the future, inspect your bathroom scales and provide an exact number.
Here is what the research tells us and what it does not.
A Quick Introduction to Foundayo
Foundayo is the brand name for orforglipron, a prescription-only GLP-1 medicine developed by Eli Lilly. It was authorised in the UK in August 2026 for weight management and insufficiently controlled type 2 diabetes.
Unlike several existing GLP-1 treatments, Foundayo is taken as a once-daily tablet rather than an injection. It works by activating GLP-1 receptors involved in appetite. This can help you feel fuller, reduce hunger and manage food cravings, potentially making a reduced-calorie


